Minnan Yang

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Zhen Cui, Pan Liu, Nan Wang et al. · Cell · 2022 · 460 citations · Full text

The architecture of the SARS-CoV-2 RNA genome inside virion

Changchang Cao, Zhaokui Cai, Xia Xiao et al. · Nature Communications · 2021 · 206 citations · Full text

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · 2020 · 95 citations · Full text

Placebo-controlled Phase 2, Immunology, Vaccine Hesitancy +18